Movement Disorders
Juvenile Huntington disease
Dec. 27, 2023
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Two nonexclusive hypotheses of hyperornithinemia action in pathophysiology of gyrate atrophy. In one, high ornithine concentration inhibits AGAT (arginine:glycine amidinotransferase) with subsequent lowering of guanidinoacetate, creatine, and phosphocreatine. In the other, high ornithine inhibits the P5C (delta1 pyrroline-5-carboxylate) synthase. These changes combined with the inherited deficiency of ornithine aminotransferase (black rectangle) result in decreased formation of P5C and proline. (Contributed by Dr. Andreas Schulze.)